Actinoplanes utahensis
| Actinoplanes utahensis | |
|---|---|
| Scientific classification | |
| Domain: | |
| Phylum: | |
| Class: | |
| Order: | |
| Family: | |
| Genus: | |
| Species: | A. utahensis |
| Binomial name | |
| Actinoplanes utahensis Couch 1963 | |
Actinoplanes utahensis is a species of bacteria and a source of the drug acarbose, an alpha-glucosidase inhibitor used in the treatment of diabetes mellitus.
Description
A. utahensis are irregular in size and shape. They form sporangia which are 5 to 18 micrometers in diameter, and contain spores arranged in irregular coils. A. utahensis are motile by way of a number of flagella at one end.[1]
History
A. utahensis was originally identified by John Couch from soils collected from Salt Lake City's Liberty Park as well as along U.S. Route 40 in Nevada.[2]
References
- ↑ Vobis G, Schafer J, Kampfer P (14 September 2015). "Actinoplanes". In Whitman WB (ed.). Bergey's Manual of Systematics of Archaea and Bacteria. John Wiley & Sons. doi:10.1002/9781118960608.gbm00139.
- ↑ "Some New Genera and Species of the Actinoplanaceae". Journal of the Elisha Mitchell Scientific Society. 79: 69. May 1963. Retrieved 15 October 2017.
External links
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.